These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2285840)

  • 1. The effect of a needle and syringe exchange on a methadone maintenance unit.
    Wolk J; Wodak A; Guinan JJ; Macaskill P; Simpson JM
    Br J Addict; 1990 Nov; 85(11):1445-50. PubMed ID: 2285840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance and needle/syringe sharing.
    Longshore D; Hsieh S; Danila B; Anglin MD
    Int J Addict; 1993 Aug; 28(10):983-96. PubMed ID: 8407026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour.
    Hartgers C; Buning EC; van Santen GW; Verster AD; Coutinho RA
    AIDS; 1989 Sep; 3(9):571-6. PubMed ID: 2506902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.
    McNeely J; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2006 Jul; 31(1):51-7. PubMed ID: 16814010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Risky Drug Use Behaviors by Enrolling Syringe Exchange Registrants in Methadone Maintenance.
    Kidorf M; Brooner RK; Leoutsakos JM; Peirce J
    Subst Use Misuse; 2021; 56(4):546-551. PubMed ID: 33616479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987.
    Wolk J; Wodak A; Morlet A; Guinan JJ; Wilson E; Gold J; Cooper DA
    AIDS; 1988 Oct; 2(5):373-7. PubMed ID: 3146266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for reducing HIV transmission related to the dead space in needles and syringes.
    Zule WA; Pande PG; Otiashvili D; Bobashev GV; Friedman SR; Gyarmathy VA; Des Jarlais DC
    Harm Reduct J; 2018 Jan; 15(1):3. PubMed ID: 29334973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs.
    Des Jarlais DC; Paone D; Friedman SR; Peyser N; Newman RG
    Am J Public Health; 1995 Nov; 85(11):1577-84. PubMed ID: 7485676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National survey of syringe exchange schemes in England.
    Lart R; Stimson GV
    Br J Addict; 1990 Nov; 85(11):1433-43. PubMed ID: 2285839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A needle in the haystack--the dire straits of needle exchange in Hungary.
    Gyarmathy VA; Csák R; Bálint K; Bene E; Varga AE; Varga M; Csiszér N; Vingender I; Rácz J
    BMC Public Health; 2016 Feb; 16():157. PubMed ID: 26880660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringe exchange in Germany.
    Weber U; Schneider W
    Subst Use Misuse; 1998 Apr; 33(5):1093-112. PubMed ID: 9596378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot syringe exchange program in Washington, DC.
    Vlahov D; Ryan C; Solomon L; Cohn S; Holt MR; Akhter MN
    Am J Public Health; 1994 Feb; 84(2):303-4. PubMed ID: 8296961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers.
    Wodak A; Dolan K; Imrie AA; Gold J; Wolk J; Whyte BM; Cooper DA
    Med J Aust; 1987 Sep; 147(6):275-6. PubMed ID: 3650679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.
    Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV
    Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and harm reduction for injection drug users.
    Brettle RP
    AIDS; 1991 Feb; 5(2):125-36. PubMed ID: 2031687
    [No Abstract]   [Full Text] [Related]  

  • 20. Hitting up in the top end: characteristics of needle exchange clients in Darwin.
    Roberts C; Crofts N
    Aust N Z J Public Health; 2000 Feb; 24(1):82-5. PubMed ID: 10777985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.